100 related articles for article (PubMed ID: 8026832)
1. Immunolocalization of platelet-derived growth factor, transforming growth factor-beta, and fibronectin in acute megakaryoblastic leukemia manifesting tumor formation.
Kitagawa M; Yoshida S; Ishige I; Minami J; Kuwata T; Tanizawa T; Kamiyama R
Hum Pathol; 1994 Jul; 25(7):723-6. PubMed ID: 8026832
[TBL] [Abstract][Full Text] [Related]
2. A new fibroblast growth stimulating activity from the human megakaryoblastic leukaemia cell line ELF-153: in vitro and in vivo findings.
Hassan HT; Hanauske AR; Lux E; Kleine HD; Freund M
Int J Exp Pathol; 1995 Oct; 76(5):361-7. PubMed ID: 7488550
[TBL] [Abstract][Full Text] [Related]
3. The production of transforming growth factor-beta in acute megakaryoblastic leukemia and its possible implications in myelofibrosis.
Terui T; Niitsu Y; Mahara K; Fujisaki Y; Urushizaki Y; Mogi Y; Kohgo Y; Watanabe N; Ogura M; Saito H
Blood; 1990 Apr; 75(7):1540-8. PubMed ID: 2317561
[TBL] [Abstract][Full Text] [Related]
4. Characterization of an acute micromegakaryocytic leukaemia: evidence for the pathogenesis of myelofibrosis.
Reilly JT; Barnett D; Dolan G; Forrest P; Eastham J; Smith A
Br J Haematol; 1993 Jan; 83(1):58-62. PubMed ID: 8435338
[TBL] [Abstract][Full Text] [Related]
5. Growth factor expression following clinical mandibular distraction osteogenesis in humans and its comparison with existing animal studies.
Knabe C; Nicklin S; Yu Y; Walsh WR; Radlanski RJ; Marks C; Hoffmeister B
J Craniomaxillofac Surg; 2005 Dec; 33(6):361-9. PubMed ID: 16253513
[TBL] [Abstract][Full Text] [Related]
6. Immunolocalization of cytokines and growth factors in oral submucous fibrosis.
Haque MF; Harris M; Meghji S; Barrett AW
Cytokine; 1998 Sep; 10(9):713-9. PubMed ID: 9770333
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair.
Pierce GF; Tarpley JE; Yanagihara D; Mustoe TA; Fox GM; Thomason A
Am J Pathol; 1992 Jun; 140(6):1375-88. PubMed ID: 1376557
[TBL] [Abstract][Full Text] [Related]
8. Enhanced expression of transforming growth factor beta during megakaryoblastic differentiation of K562 leukemia cells.
Alitalo R; Mäkelä TP; Koskinen P; Andersson LC; Alitalo K
Blood; 1988 Apr; 71(4):899-906. PubMed ID: 3162693
[TBL] [Abstract][Full Text] [Related]
9. Expression of growth factor peptides and their receptors in neuroendocrine tumors of the digestive system.
Chaudhry A; Funa K; Oberg K
Acta Oncol; 1993; 32(2):107-14. PubMed ID: 8391829
[TBL] [Abstract][Full Text] [Related]
10. Megakaryocytic leukemia and platelet factor 4.
Ryo R; Yasunaga M; Saigo K; Yamaguchi N
Leuk Lymphoma; 1992 Nov; 8(4-5):327-36. PubMed ID: 1337850
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factor, insulin-like growth factors, fibroblast growth factors and transforming growth factor beta do not account for the cell growth activity present in bovine milk.
Belford DA; Rogers ML; Francis GL; Payne C; Ballard FJ; Goddard C
J Endocrinol; 1997 Jul; 154(1):45-55. PubMed ID: 9246937
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts.
Kimura A; Katoh O; Hyodo H; Kuramoto A
Br J Haematol; 1989 Aug; 72(4):486-91. PubMed ID: 2789074
[TBL] [Abstract][Full Text] [Related]
13. Cellular distribution of platelet-derived growth factor, transforming growth factor-beta, basic fibroblast growth factor, and their receptors in normal bone marrow.
Yoon SY; Tefferi A; Li CY
Acta Haematol; 2000; 104(4):151-7. PubMed ID: 11279303
[TBL] [Abstract][Full Text] [Related]
14. Chronic myelogenous leukemia terminating in acute megakaryoblastic leukemia. Case report.
Bourantas KL; Repousis P; Tsiara S; Christou L; Konstantinidou P; Bai M
J Exp Clin Cancer Res; 1998 Jun; 17(2):243-5. PubMed ID: 9700588
[TBL] [Abstract][Full Text] [Related]
15. Detection and quantification of transforming growth factor beta (TGF-beta) and platelet-derived growth factor (PDGF) release by normal human megakaryocytes.
Wickenhauser C; Hillienhof A; Jungheim K; Lorenzen J; Ruskowski H; Hansmann ML; Thiele J; Fischer R
Leukemia; 1995 Feb; 9(2):310-5. PubMed ID: 7869769
[TBL] [Abstract][Full Text] [Related]
16. Childhood acute megakaryoblastic leukemia with internalization of hemic cells.
Shimizu H; Ui T; Sasaki K; Kawai S; Kaneko Y; Fujimoto T
Am J Pediatr Hematol Oncol; 1990; 12(4):477-9. PubMed ID: 2285130
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical localization of growth factors in fetal wound healing.
Whitby DJ; Ferguson MW
Dev Biol; 1991 Sep; 147(1):207-15. PubMed ID: 1879607
[TBL] [Abstract][Full Text] [Related]
18. Matrix protein synthesis by glomerular mesangial cells in culture: effects of transforming growth factor beta (TGF beta) and platelet-derived growth factor (PDGF) on fibronectin and collagen type IV mRNA.
Hänsch GM; Wagner C; Bürger A; Dong W; Staehler G; Stoeck M
J Cell Physiol; 1995 Jun; 163(3):451-7. PubMed ID: 7775588
[TBL] [Abstract][Full Text] [Related]
19. High expression of platelet-derived growth factor and transforming growth factor-beta 1 in blast cells from patients with Down Syndrome suffering from transient myeloproliferative disorder and organ fibrosis.
Hattori H; Matsuzaki A; Suminoe A; Ihara K; Nakayama H; Hara T
Br J Haematol; 2001 Nov; 115(2):472-5. PubMed ID: 11703351
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta1 induces tumor stroma and reduces tumor infiltrate in cervical cancer.
Hazelbag S; Gorter A; Kenter GG; van den Broek L; Fleuren G
Hum Pathol; 2002 Dec; 33(12):1193-9. PubMed ID: 12514788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
